Abbott Ventricular Tachycardia PAS
Public ClinicalTrials.gov record NCT05839873. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Abbott Ventricular Tachycardia Post Approval Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This post-approval study (PAS) is designed to provide continued clinical evidence to confirm the long-term safety and effectiveness of the FlexAbilityTM Ablation Catheter, Sensor EnabledTM (FlexAbility SE) for the treatment of ventricular tachycardia in a post-market environment. This is a prospective, single arm, open-label, multi-center, observational study.
Study identification
- NCT ID
- NCT05839873
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 62 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 7 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 23, 2023
- Primary completion
- Jul 31, 2026
- Completion
- Oct 31, 2026
- Last update posted
- Oct 19, 2025
2023 – 2026
United States locations
- U.S. sites
- 11
- U.S. states
- 11
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| NCH Healthcare System | Naples | Florida | 34102 | — |
| St. Vincent Hospital | Indianapolis | Indiana | 46240-0970 | — |
| Kansas City Cardiac Arrhythmia Research Foundation | Overland Park | Kansas | 66211 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| VA Medical Center Minneapolis | Minneapolis | Minnesota | 55417 | — |
| Carolinas Medical Center | Charlotte | North Carolina | 28203 | — |
| Integris Baptist Medical Center | Oklahoma City | Oklahoma | 73112 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Vanderbilt Heart & Vascular Institute | Nashville | Tennessee | 37232 | — |
| Baylor Scott & White Heart & Vascular Hospital | Dallas | Texas | 75226 | — |
| University of Utah Hospital | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05839873, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 19, 2025 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05839873 live on ClinicalTrials.gov.